Clinical Trial Update: Trastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage IV Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating trastuzumab with or without tamoxifen in women with progressive Stage IV breast cancer has been withdrawn from clinical testing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Stage IV Breast Cancer, Recurrent Breast Cancer | Phase 3 | Status: WITHDRAWN